Hold-rated reports

932 tickers rated Hold
Ranks this page's recent reports by score.
Mirion Technologies, Inc.
MIR·Industrials
B ★★★Hold
Current$18.37
Target$20.10
Return+9.4%
Oct 31, 2026

Mirion benefits from long-term nuclear safety and radiation technology demand, supported by accelerating orders and cash generation, but acquisition-related dilution, leverage, and a demanding earnings multiple limit near-term upside.

Score
67
The Vita Coco Company, Inc.
COCO·Consumer Staples
B ★★★Hold
Current$58.48
Target$63.45
Return+8.5%
Oct 31, 2026

Vita Coco combines leading coconut water brand equity, strong organic demand, and expanding global distribution, but acquisition-driven growth and volatile input costs create uncertainty around sustainable margins and valuation.

Score
71
First Interstate BancSystem, Inc.
FIBK·Financials
B ★★★Hold
Current$37.65
Target$40.49
Return+7.5%
Oct 31, 2026

First Interstate offers attractive dividend income, strong capital and improving lending margins, but persistent loan runoff, uneven profitability and credit-cost pressure limit the near-term upside.

Score
73
Independence Realty Trust, Inc.
IRT·Real Estate
B ★★★Hold
Current$14.72
Target$17.22
Return+17.0%
Oct 31, 2026

IRT combines recurring apartment rental cash flow, an attractive dividend, and potential Centerspace merger synergies, but elevated leverage, apartment supply pressure, and integration uncertainty limit conviction.

Score
71
Concentra Group Holdings Parent, Inc.
CON·Healthcare
B ★★★Hold
Current$40.38
Target$41.00
Return+1.5%
Oct 31, 2026

Concentra's national occupational healthcare network and improving cash generation support durable earnings growth, but elevated valuation multiples and acquisition-related leverage constrain prospective returns.

Score
69
WesBanco, Inc.
WSBC·Financials
B ★★★Hold
Current$38.49
Target$42.00
Return+9.1%
Oct 31, 2026

WesBanco combines a dependable regional banking franchise, attractive dividends, and organic loan growth opportunities, but rising credit stress and wholesale funding dependence could undermine earnings and capital returns.

Score
65
Extreme Networks, Inc.
EXTR·Technology
B ★★★Hold
Current$22.61
Target$27.40
Return+21.2%
Oct 31, 2026

Extreme Networks offers a credible enterprise networking recovery supported by accelerating SaaS adoption and stronger cash generation, but intense competition and significant stock compensation limit its valuation upside.

Score
71
Veracyte, Inc.
VCYT·Healthcare
B ★★★Hold
Current$50.01
Target$57.74
Return+15.5%
Oct 31, 2026

Veracyte combines growing genomic cancer testing demand, improving margins, and strong cash generation with promising new oncology products, but premium valuation and reimbursement dependence constrain near-term upside.

Score
68
Oceaneering International, Inc.
OII·Energy
B ★★★Hold
Current$40.86
Target$45.22
Return+10.7%
Oct 31, 2026

Oceaneering combines differentiated subsea robotics, strong free cash flow, and aerospace and defense diversification, but offshore cyclicality, weakening manufactured-products backlog, and a historical valuation premium limit near-term upside.

Score
68
Methanex Corporation
MEOH·Materials
B ★★★Hold
Current$71.57
Target$70.00
Return-2.2%
Oct 31, 2026

Methanex combines global methanol leadership, strong cash generation and deleveraging potential, but its attractive headline multiples depend heavily on whether favorable commodity prices persist.

Score
73
EPR Properties
EPR·Real Estate
B ★★★Hold
Current$57.71
Target$63.25
Return+9.6%
Oct 31, 2026

EPR offers attractive monthly dividend income and growing experiential property cash flows, but rising leverage, tenant concentration, and acquisition-related dilution limit its margin of safety.

Score
74
SLM Corporation
SLM·Financials
B ★★★Hold
Current$17.80
Target$21.20
Return+19.1%
Oct 31, 2026

SLM offers recovery potential through low valuation multiples, strong private education loan demand, and share repurchases, but rising credit provisions and weaker net interest margins threaten sustainable earnings.

Score
71